References
- Church, M. K. (2011). Safety and efficacy of bilastine: a new H1-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria. Exp Opin Drug Saf 10:779–793.
- Ciarimboli, G. (2011). Role of organic cation transporters in drug-induced toxicity. Exp Opin Drug Metab Toxicol 7:159–174.
- Crean, C., Valiente, R., Sologuren, A., McLaverty, D. (2007). Effect of grapefruit juice on the pharmacokinetics of bilastine. 36th Annual Meeting of the American College of Clinical Pharmacology, San Francisco, California, USA, September 9–11, 2007. Abstract 71. J Clin Pharmacol 47:1198.
- European Medicines Agency. (2010). Guideline on the investigation of drug interactions (draft). CPMP/EWP/560/95/Rev. 1 – Corr.* April 22, 2010. Available at: http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/05/WC500090112.pdf. Accessed on March 19, 2012.
- Evers, R., Zaman, G. J., van Deemter, L., Jansen, H., Calafat, J., Oomen, L. C., et al. (1996). Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 97:1211–1218.
- Food and Drug Administration. (2012). Drug interaction studies—study design, data analysis, implications for dosing, and labeling recommendations. Guidance for industry (draft). February 2012. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM292362.pdf. Accessed on March 19, 2012.
- Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., et al.; International Transporter Consortium. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9:215–236.
- Glavinas, H., Krajcsi, P., Cserepes, J., Sarkadi, B. (2004). The role of ABC transporters in drug resistance, metabolism, and toxicity. Curr Drug Deliv 1:27–42.
- Gonzalo, A., Lucero, M. L. (2008). Identification of processes involved in bilastine bioavailability in rats. Drug Metab Rev 40(Suppl. 1):42–43.
- Jauregizar, N., de la Fuente, L., Lucero, M. L., Sologuren, A., Leal, N., Rodríguez, M. (2009). Pharmacokinetic/pharmacodynamic modelling of the antihistaminic H1 effect of bilastine. Clin Pharmacokinet 48:543–554.
- Kalliokoski, A., Niemi, M. (2009). Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158:693–705.
- Löscher, W. Potschka, H. (2005). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. Neurotherapeutics 2:86–98.
- Ming, X., Knight, B. M., Thakker, D. R. (2011). Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters. Mol Pharm 8:1677–1686.
- Mizuno, N., Niwa, T., Yotsumoto, Y., Sugiyama, Y. (2003). Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55:425–461.
- Shitara, Y., Horie, T., Sugiyama, Y. (2006). Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 27:425–446.
- Shugarts, S., Benet, L. Z. (2009). The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 26:2039–2054.
- Tsuji, A. (2002). Transporter-mediated drug interactions. Drug Metab Pharmacokinet 17:253–274.
- Tsuji, A. (2005). Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. Neurotherapeutics 2:54–62.
- Tyl, B., Kabbaj, M., Azzam, S., Sologuren, A., Valiente, R., Reinbolt, E., et al. (2011). Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a Thorough QT Study (TQTS) with QT-concentration analysis. J Clin Pharmacol 2011 June 3. doi: 10.1177/0091270011407191. [Epub ahead of print].
- van Montfoort, J. E., Hagenbuch, B., Groothuis, G. M., Koepsell, H., Meier, P. J., Meijer, D. K. (2003). Drug uptake systems in liver and kidney. Curr Drug Metab 4:185–211.
- Zhang, L., Zhang, Y. D., Strong, J. M., Reynolds, K. S., Huang, S. M. (2008). A regulatory viewpoint on transporter-based drug interactions. Xenobiotica 38:709–724.